Direxion Daily S&P Biotech Bear 3X ETF

LABD

Market cap $61.5M

Although the equities market often embodies chaos and capricious non-linearity, few sectors witness as much kinetic wildness like biotechnology. At its core, biotech represents an innovative push toward addressing the human condition — which is often found to be shockingly frail.

Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

Market volatility boosts demand for leveraged and inverse-leveraged ETFs. A few of them gained more than 25% last month.

Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

Inverse and volatility ETFs won in the worst week of Wall Street since 2020.

Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

Editor's note: Any and all references to time frames longer than one trading day are for purposes of market context only, and not recommendations of any holding time frame. Daily rebalancing ETFs are not meant to be held unmonitored for long periods.

Editor's note: Any and all references to time frames longer than one trading day are for purposes of market context only, and not recommendations of any holding time frame. Daily rebalancing ETFs are not meant to be held unmonitored for long periods.

The U.S. stock market wrapped up April with losses, snapping a five-month winning streak and marking the market's worst month of 2024. This has resulted in huge gains for inverse or inverse-leveraged ETFs.

These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.